dialysis overview
Contents
principles
Two jobs, handled separately:
- Solvent (water) clearance — ultrafiltration via pressure gradient: barometric (HD) or osmotic (PD)
- Solute clearance — diffusion (concentration gradient across membrane) + convection (solute dragged with water movement)
access
| Type | Details | Notes |
|---|---|---|
| Temporary catheter | Non-tunnelled, internal jugular or femoral | Short-term only; reassess daily |
| Tunnelled catheter (PermCath) | Subcutaneous cuff, internal jugular | Bridge to permanent access or when AVF/AVG not feasible |
| AVF | Native arteriovenous fistula | Preferred — lowest infection/thrombosis; needs 2–3 months to mature |
| AVG | Synthetic graft | Usable in ~2–4 weeks; higher thrombosis/infection than AVF |
Avoid CVL/PICC lines in CKD patients whenever possible — venous stenosis/thrombosis destroys future access sites. Minimise venipuncture in dialysis patients; draw labs from the dialysis circuit 3x/week.
haemodialysis prescription
Standard chronic HD:
| Parameter | Default |
|---|---|
| Frequency | 3x/week (MWF or TuThSa) |
| Duration | 4 h |
| Blood flow (Qb) | 400 mL/min |
| Dialysate flow (Qd) | 500 mL/min |
| Dialysate Na | 140 mmol/L (should not exceed serum Na by >10) |
| Dialysate K | Rule of 7 minus pre-dialysis K (options: 1, 1.5, 3, 4 mmol/L) |
| Dialysate HCO3 | 30–40 mmol/L |
| Dialysate Ca | 1.25 or 1.50 mmol/L |
| UF rate | Avoid >13 mL/kg/hr (~1 L/hr for 70 kg) |
| Anticoagulation | Dalteparin 2500 units (tight) |
Dalteparin contraindications: HIT, pericarditis, new HD starts, recent major bleeding or surgery.
new HD start
Gradual ramp to avoid dialysis disequilibrium syndrome (cerebral oedema from rapid osmolality shifts):
| Day 1 | Day 2 | Day 3 | |
|---|---|---|---|
| Duration | 2 h | 3 h | 4 h |
| Qb | 200 mL/min | 300 mL/min | 400 mL/min |
| Qd | 300 mL/min | 400 mL/min | 500 mL/min |
| Anticoagulation | None | None | Start as appropriate |
CRRT
ICU-only modality for haemodynamically unstable patients who cannot tolerate intermittent HD.
- Default mode: CVVHD (continuous venovenous haemodialysis)
- Filters changed every 72 h — natural reassessment point: still need CRRT or ready for intermittent HD?
- Machine taken down for off-unit transport; fresh filter on return
- Anticoagulation escalation: none (default) → regional citrate (if filter clotting) → systemic heparin
- Cost: ~250/treatment
STARRT-AKI (2020) showed no mortality benefit from early RRT initiation. Modality choice (CRRT vs iHD) is driven by haemodynamic tolerance, not timing.
peritoneal dialysis
Home-based therapy using the peritoneal membrane as the dialysis surface. Dextrose-based dialysate creates an osmotic gradient for fluid removal.
solutions
| Solution | Composition | Notes |
|---|---|---|
| Dianeal 1.5% | Dextrose ~8.3 mmol/L glucose | Standard |
| Dianeal 2.5% | Dextrose ~13.9 mmol/L glucose | More UF |
| Dianeal 4.25% | Dextrose ~23.6 mmol/L glucose | Maximum UF; significant glucose load |
| Extraneal (icodextrin) | Glucose polymer | Minimal glucose absorption — preferred for diabetics and long dwells |
modalities
- CAPD — continuous ambulatory PD: manual exchanges, typically 4x/day
- APD/CCPD — automated/continuous cycling PD: machine performs overnight exchanges
Generally continue home PD prescription during hospital admission. Modify for volume overload (higher concentration) or hyperkalaemia.
Dianeal dextrose loads can cause significant hyperglycaemia — adjust insulin accordingly. Extraneal (icodextrin) has minimal glucose effect but interferes with some glucometer readings (maltose cross-reactivity).
practical points
- No need to repeat lytes post-HD unless concerned about dialysis adequacy or persistent hyperkalaemia — they will be transiently abnormal
- Do not correct serum K in dialysis patients unless <2 mmol/L or symptomatic — risk of rebound hyperkalaemia
- Dialysis nurses are experienced — ask them when unsure about access or prescription logistics
Key references
- guidelineKDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020.